Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements in Participants With Breast, Colorectal, Upper Gastrointestinal, or Prostate Cancer

Evaluating Nutritional Preferences and Product Accessibility in Oral Nutritional Supplements for Oncologic Patients - A Cross-Sectional Survey Study at Norris Comprehensive Cancer Center

Status

Withdrawn

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03563352

Enrollment

Registered

2018-06-20

Start date

2018-08-30

Completion date

2020-09-24

Last updated

2020-12-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast Carcinoma, Cholangiocarcinoma, Colorectal Carcinoma, Gastric Carcinoma, Malignant Digestive System Neoplasm, Pancreatic Carcinoma, Prostate Carcinoma

Brief summary

This trial studies nutritional preferences and product accessibility in oral nutritional supplements in participants with breast, colorectal, upper gastrointestinal, or prostate cancer. Learning what participants like and dislike about their current or past used nutritional supplements may help doctor know how to improve them.

Detailed description

PRIMARY OBJECTIVES: I. Identify how patients with cancer are obtaining nutrition to support medical management. SECONDARY OBJECTIVES: I. Examine associations of gastrointestinal side effects with specific diagnoses and respective medical therapies. II. Understand how patients access information regarding nutritional supplements. III. Evaluate patient satisfaction with currently available oral nutritional supplements (ONS). IV. Identify patient preferences in formulating a novel nutritional supplement. OUTLINE: Participants attend an interview over 15 minutes and complete surveys.

Interventions

OTHERInterview

Attend an interview

OTHERSurvey Administration

Ancillary studies

Study design

Observational model

CASE_ONLY

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Ability to comprehend English (both reading and writing) * Subjects in the inpatient and outpatient setting with the diagnosis of breast cancer, colorectal cancer, upper gastrointestinal cancer (including gastric, pancreatic, and cholangiocarcinoma), or prostate cancer * Receiving chemotherapy, biologic, or hormonal therapy in the University of Southern California (USC) Norris Comprehensive Cancer Center Day Hospital * Ability to understand and the willingness to sign a written informed consent

Exclusion criteria

* Patients with a mental disability that makes them unable to understand and respond to the questions * Patients with reported non-oncologic associated deficits in taste and smell

Design outcomes

Primary

Measure	Time frame	Description
The way patients with cancer choose and obtain nutritional supplements to support medical management	Up to 1 year	Data from the oral nutritional supplement survey that examines quality, quantity, access and affordability of oral nutrional supplements will be summarized.

Secondary

Measure	Time frame	Description
Associations of gastrointestinal side effects with specific diagnoses and respective medical therapies	Up to 1 year	Data from the survey will be used for testing the association of gastrointestinal side effects with specific diagnosis and medical therapies.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026